Log In Get Started
Insider Trading March 13, 2026

Kratos Director Executes $443,000 Stock Sale as Company Advances Multiple Defense Programs

Director Jarvis sells 5,000 KTOS shares under a 10b5-1 plan amid contracts, a planned equity offering and program milestones

By Leila Farooq KTOS
Kratos Director Executes $443,000 Stock Sale as Company Advances Multiple Defense Programs
KTOS

Jarvis Scot B., a director at Kratos Defense & Security Solutions (KTOS), sold 5,000 shares on March 12, 2026, for $88.6 per share, generating $443,000. The transaction, carried out under a pre-existing 10b5-1 plan adopted September 15, 2025, leaves Jarvis with 85,417 shares. The sale occurs alongside several corporate developments including a $7 million Counter-UAS production contract, progress on an uncrewed combat aircraft system with Airbus, a $1.17 billion equity offering plan, Stifel's reaffirmed Buy rating with a $134.00 price target, and deployment of Kratos’s OpenSpace Platform by SSC Space. InvestingPro flagged KTOS as appearing overvalued versus its Fair Value. These items arrive against a backdrop of heightened tensions in the Middle East and rising investor interest in defense names.

Key Points

  • Director Jarvis sold 5,000 KTOS shares on March 12, 2026 at $88.6 per share under a 10b5-1 plan, leaving him with 85,417 shares.
  • Kratos secured a $7 million production contract for a Counter-UAS System and is advancing an uncrewed combat aircraft program with Airbus, with a maiden flight expected later this year; its OpenSpace Platform was deployed by SSC Space for small-satellite services.
  • Kratos disclosed a $1.17 billion equity share offering; InvestingPro reports the stock appears overvalued relative to Fair Value, and Stifel reaffirmed a Buy rating with a $134.00 target.

Insider transaction

Jarvis Scot B., a director at Kratos Defense & Security Solutions (NASDAQ:KTOS), disposed of 5,000 shares of common stock on March 12, 2026, at $88.6 per share, producing proceeds of $443,000. The trade was executed pursuant to a pre-arranged 10b5-1 trading plan that the director adopted on September 15, 2025. After the sale, Jarvis directly holds 85,417 shares of Kratos stock.

Company activity and contracts

Kratos has recorded several operational and commercial developments concurrent with the insider sale. The company secured a $7 million production contract for a Counter-UAS System designed to detect and track threats including unmanned aerial systems and cruise missiles. In addition, Kratos and Airbus are advancing work on an uncrewed combat aircraft system for the German Air Force, with a maiden flight expected later this year.

Separately, Kratos disclosed plans for a $1.17 billion equity share offering. Following the offering announcement, Stifel maintained a Buy rating on the stock and left its price target unchanged at $134.00.

Technology deployments

Kratos’s OpenSpace Platform has been deployed by SSC Space to support the SSC Space Go service. That service is described as backing satellite operations and data delivery for small satellites operating in Low Earth Orbit.

Valuation and market context

According to InvestingPro analysis cited alongside the transactions, KTOS currently appears overvalued relative to its calculated Fair Value. Investors are pointed toward a comprehensive Pro Research Report that includes 17+ InvestingPro Tips for deeper valuation context.

These corporate announcements and the director’s share sale arrive amid heightened tensions in the Middle East, a backdrop that the article notes has contributed to increased investor interest in defense stocks.

What this means

The public disclosure documents the mechanics of the director’s sale and situates it within a period of active contract awards, program milestones and planned capital-raising at Kratos. The combination of a sizeable planned equity offering and an InvestingPro note on valuation are factual data points that market participants can use when assessing the company’s near-term capital structure and valuation. At the same time, the company’s contract wins and technology deployments are factual operational developments that may factor into future commercial performance.

Risks

  • Valuation risk - InvestingPro analysis indicates KTOS appears overvalued relative to its Fair Value, which could affect investor expectations for returns. (Impacted sectors: equities, defense stocks.)
  • Capital structure risk - The planned $1.17 billion equity share offering could dilute existing shareholders and alter the company's financing profile. (Impacted sectors: capital markets, defense companies.)
  • Geopolitical-driven volatility - Heightened tensions in the Middle East have increased interest in defense stocks, which can introduce demand volatility tied to geopolitical developments. (Impacted sectors: defense, aerospace.)

More from Insider Trading

Adaptive Biotechnologies President Rubinstein Disposes of $2.37M in ADPT Shares, Exercises Options Mar 13, 2026 ACM Research CFO Sells $4.49M in Stock; Exercises Options as Q4 Results Miss Estimates Mar 13, 2026 Lantronix CPO Disposes $89.8K in Shares as Company Posts Modest Q2 Beat on EPS Mar 13, 2026 Adaptive Biotechnologies Director Disposes $214,130 of Shares Following Strong Quarterly Results Mar 13, 2026 Adaptive Biotechnologies CFO Executes $245,910 'Sell to Cover' Stock Sale Mar 13, 2026